Lijana R C, Williams M C
J Lab Clin Med. 1979 Aug;94(2):266-76.
Plasma hemoglobin is routinely measured by some modification of the benzidine-hydrogen peroxide method, particularly at low concentrations. Because benzidine is carcinogenic, and thus impractical for clinical use under current restrictions, the identification of a noncarcinogenic benzidine derivative has become important. 3,3',5,5'-tetramethylbenzidine fulfills this criterion, and consequently a method is described in this paper which uses it for hemoglobin determinations in the range of 1 to 100 mg/dl. Absorption spectra show this method to be far less influenced by plasma proteins and other substances than the benzidine method, and moreover the sensitivity of TMB is at least seven times that of benzidine under comparable conditions.
血浆血红蛋白通常采用联苯胺 - 过氧化氢法的某种改良方法进行测定,尤其是在低浓度时。由于联苯胺具有致癌性,因此在当前限制条件下不适合临床使用,所以鉴定一种非致癌性的联苯胺衍生物变得很重要。3,3',5,5'-四甲基联苯胺符合这一标准,因此本文描述了一种使用它来测定1至100mg/dl范围内血红蛋白的方法。吸收光谱表明,该方法受血浆蛋白和其他物质的影响远小于联苯胺法,而且在可比条件下,TMB的灵敏度至少是联苯胺的七倍。